NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-194-2005-0-PCT-02 PROBE FOR NUCLEIC ACID SEQUENCING AND METHODS OF USE PCT PCT PCT/US2006/047534 Expired
NCI E-195-2005-0-PCT-02 NANOPROBES FOR DETECTION OR MODIFICATION OF MOLECULES PCT PCT PCT/US2006/047456 Expired
NCI E-194-2005-0-EP-06 PROBE FOR NUCLEIC ACID SEQUENCING AND METHODS OF USE EP DIV 10176710.1 Abandoned
NCI E-194-2005-0-JP-05 PROBE FOR NUCLEIC ACID SEQUENCING AND METHODS OF USE JP National Stage 2008-545768 Abandoned
NIAID E-173-2004-1-CN-04 Methods of Using Adenoviral Vector to Induced an Immune Response CN National Stage 200580019211.9 Abandoned
NCI E-048-1997-0-US-29 METHODS OF GENE THERAPY USING NUCLEIC ACID SEQUENCES FOR ATP-BINDING CASSETTE TRANSPORTER US CON 11/636,909 8129353 Expired PDF
NCI E-150-2001-1-US-02 Use of a Promotor of T-Cell Expansion And an Inducer of CD40 Stimulation in The Treatment or Prevention of a Pathologic State US DIV 11/608,873 7368106 Abandoned PDF
NCI E-103-2006-2-PCT-01 METHODS AND COMPOSITIONS FOR ASSESSING ALTERATIONS IN GENE EXPRESSION PATTERNS IN CLINICALLY NORMAL TISSUES OBTAINED FROM HETEROZYGOUS CARRIERS OF MUTANT GENES ASSOCIATED WITH CANCER AND METHODS OF USE THEREOF PCT PCT COMB PCT/US2006/047222 Expired
NIA E-081-2007-0-US-01 A Cancer Chemoprevention Strategy Based On Loss Of Imprinting Of IGF2 US 60/873,830 Abandoned
NCI E-075-2004-2-US-05 Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells US National Stage 11/629,233 Abandoned
NIAID E-055-2007-0-US-01 Use of Antagonists of the Interaction Between HIV Gp120 And Intregrin US 60/873,884 Abandoned
NCI E-321-2006-0-US-01 Regulation Of Skin Characteristics By Dickkopf 1 (DKK1) US 60/873,874 Abandoned
NICHD E-280-2002-0-US-05 Method for Tissue Osmometry US CON 11/567,105 7380477 Expired PDF
NCI E-177-2006-0-US-01 ANTI-TREM-LIKE TRANSCRIPT-1 (TLT-1) ANTIBODIES, METHODS, AND COMPOSITIONS US ORD 11/634,331 7553936 Abandoned PDF
NCI E-025-2006-0-EP-06 Anti-Viral Griffithsin Compounds, Compositions, and Methods EP DIV 10014895.6 Abandoned
NCI E-025-2006-0-EP-04 Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use EP National Stage 06838737.2 Issued
NCI E-025-2006-0-DE-09 Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use DE EP 06838737.2 Issued
NCI E-025-2006-0-FR-08 Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use FR EP 06838737.2 Issued
NCI E-025-2006-0-IE-10 Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use IE EP 06838737.2 Issued
NCI E-025-2006-0-CH-12 Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use CH EP 06838737.2 Issued
NCI E-025-2006-0-GB-11 Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use GB EP 06838737.2 Issued
NCI E-062-1996-0-US-11 PROSTATE SPECIFIC ANTIGEN OLIGO-EPITOPE PEPTIDE US CON 11/606,929 7547773 Expired PDF
NCI E-163-2005-0-PCT-02 Intraperitoneal Injection Of Pseudovirions Carrying A Toxin Leads To Significantly Reduced Tumor Size PCT PCT PCT/US2006/046145 Abandoned
NCI E-308-2005-0-PCT-02 Treatment of Viral Infections PCT PCT PCT/US2006/046259 Expired
NCI E-025-2006-0-PCT-02 Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use PCT PCT PCT/US2006/045930 Expired
NICHD E-010-1998-1-US-08 PROTEIN TYROSINE KINASE SUBSTRATE LAT AND ITS USE IN THE IDENTIFICATION OF (ANT)AGONISTS OF THE KINASE US CON 11/607,719 Abandoned
NCI E-025-2006-0-EP-05 Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use EP DIV 10014894.9 Abandoned
NCI E-025-2006-0-EP-07 Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use EP DIV 10014893.1 Abandoned
NCI E-308-2005-0-EP-03 Treatment of Viral Infections EP National Stage 06838939.4 Abandoned
NIAID E-110-2006-0-US-01 USES OF MURAMYL DIPEPTIDE COMPOSITIONS FOR TREATING AND PREVENTING INFLAMMATION US 60/872,384 Abandoned
NCI E-106-2003-0-US-03 Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Use US National Stage 11/569,813 7884178 Issued PDF
NIAID E-326-2006-0-US-01 Codon-Modified Immunogenic Compositions and Methods of Use US 60/872,071 Abandoned
NIDDK E-064-2004-0-US-10 The Use Of Leptin For Treating Human Lipoatrophy US DIV 11/606,805 Abandoned
NIEHS E-170-2000-0-US-04 A Non-Steroidal Anti-Inflammatory Drug Related Gene (NAG-1) And Secreted Protein That Has Anti-Tumorigenic Properties US DIV 11/563,586 Abandoned
CC E-066-2010-0-US-01 SYSTEM AND METHOD FOR FUSING REAL-TIME ULTRASOUND IMAGES WITH PRE-ACQUIRED MEDICAL IMAGES US 60/867,221 Abandoned
NCI E-305-2006-0-US-01 Macrocyclic Grb2 SH2 Domain-binding Inhibitors Prepared Using Achiral Alkenyl Amines US 60/867,307 Abandoned
NIAID E-323-2005-2-JP-09 Vaccines Against Potential Pandemic Strains of Influenza JP National Stage 2007-515200 Abandoned
NIAID E-323-2005-3-JP-03 Influenza Hemagglutinin And Neuraminidase Variants JP National Stage 2007-515199 Abandoned
NCI E-106-2003-0-DE-19 Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production And Methods of Use DE EP 05804849.7 Expired
NCI E-106-2003-0-DE-14 Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production And Methods of Use DE EP 05804849.7 Expired
NCI E-106-2003-0-FR-20 Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production And Methods of Use FR EP 05804849.7 Expired
NCI E-106-2003-0-FR-13 Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production And Methods of Use FR EP 05804849.7 Expired
NCI E-106-2003-0-GB-21 Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production And Methods of Use GB EP 05804849.7 Expired
NCI E-106-2003-0-GB-17 Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production And Methods of Use GB EP 05804849.7 Expired
NCI E-106-2003-0-CH-18 Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production And Methods of Use CH EP 05804849.7 Expired
NCI E-106-2003-0-CH-16 Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production And Methods of Use CH EP 05804849.7 Expired
NCI E-106-2003-0-IE-22 Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production And Methods of Use IE EP 05804849.7 Expired
NCI E-106-2003-0-IE-15 Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production And Methods of Use IE EP 05804849.7 Expired
NIA E-140-2007-0-US-02 Modified Triple-helix Forming Oligonucleotides For Targeted Mutagenesis US ORD 11/562,849 8658608 Issued PDF
NIAID E-233-2003-1-US-04 Inhibition Of HIV-1 Replication By Disruption Of The Processing Of The Viral Capsid-Spacer Peptide 1 Protein US CON 11/597,431 Abandoned